Internal Medicine, Rheumatology · Kalamazoo, MI
NPI
1275533986
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
601 John St, Suite M030
Kalamazoo, MI, 49007
Phone (269) 343-3939
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
507 services
Medicare patients, 2024
207
Average age 72
Drug cost, 2024
$1.7M
3,011 prescriptions
Company payments, 2025
$647
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fadi M Ajine was code 99214 (office e&m - established), 252 times for 161 patients. In total Fadi M Ajine billed 507 services in 8 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 252 | 161 | $67.27 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 111 | 101 | $12.60 | $1,398 |
| 99205 Office E&M - New | Facility | 49 | 49 | $116.35 | $5,701 |
| 99215 Office E&M - Established | Facility | 39 | 34 | $94.22 | $3,675 |
| 20610 Joint Injection | Facility | 30 | 24 | $37.44 | $1,123 |
By year: 2022 $30K for 429 services; 2023 $25K for 357 services; 2024 $30K for 507 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fadi M Ajine prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 634 prescriptions and refills. In total Fadi M Ajine wrote 3,011 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 634 | 1,596 | 189 | $38K |
| Methotrexate Methotrexate Sodium | 503 | 1,253 | 150 | $19K |
| Methylprednisolone Generic | 446 | 902 | 152 | $9,891 |
| Prednisone Generic | 417 | 1,068 | 137 | $6,501 |
| Celecoxib Generic | 132 | 329 | 54 | $6,151 |
| Folic Acid Generic | 111 | 329 | 34 | $928 |
| Leflunomide Generic | 76 | 170 | 23 | $5,044 |
| Meloxicam Generic | 69 | 199 | 29 | $666 |
| Humira(Cf) Pen Adalimumab | 54 | 54 | Under 11 | $465K |
| Colchicine Generic | 45 | 85 | 14 | $2,729 |
| Insulin Syringe Syringe And Needle,insulin,1ml | 40 | 97 | 15 | $193 |
| Azathioprine Generic | 37 | 65 | Under 11 | $1,595 |
| Febuxostat Generic | 34 | 50 | Under 11 | $2,950 |
| Enbrel Sureclick Etanercept | 32 | 44 | Under 11 | $292K |
| Leucovorin Calcium Generic | 30 | 70 | Under 11 | $362 |
Brand drugs: 301 claims; generic drugs: 2,663 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fadi M Ajine $647 ($647 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $367.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.